ReviewNeuro-oncology2018

Evidence and context of use for contrast enhancement as a surrogate of disease burden and treatment response in malignant glioma.

Benjamin M Ellingson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.